Sinopharm vaccine was found to be safe for children aged 3 to 17, study found

Its effectiveness is not yet known, which will be evaluated in phase 3 of the investigation. The trial was randomized, double-blind, and controlled, and the boys received the two doses 28 days apart.

Regarding security, they reported that the most common side effect was pain at the injection site, followed by fever, as “most of the severity was mild to moderate” and they were “transient or resolved within a few days”.

Researchers in this study have planned that phase three for this age group will be performed in the United Arab Emirates, where vaccines will be administered 21 days apart to gain additional data on safety, immunogenicity and l ‘efficiency.

Developed by the Beijing Institute of Biologics, Sinopharm is a monovalent vaccine composed of inactivated SARS-CoV-2 virus antigens.

If the scan is successfully completed, the Chinese vaccine would be added to Pfizer and Moderna, already approved as pediatric vaccines.

A new shipment containing more than 1.5 million Sinopharm coronavirus vaccines arrived in the country on Saturday. A total of 1,536,000 doses arrived today at 7:59 pm at Ezeiza International Airport from Frankfurt, Germany on Lufthansa flight LH8264, it was officially reported.

Meanwhile, another shipment, consisting of 1,336,000 doses, will arrive Monday, at 7 am, on flight LH540, from the same airline.

The two shipments will total 2,872,000 doses of Sinopharm vaccine and will aim to “step up” the vaccination that is being rolled out across the country, the national government reported today.

Thus, with the arrival of these two planes, Argentina will have exceeded the 63 million vaccines received since the start of the vaccination plan.